Avexa is a biotechnology company focusing on the development and commercialization of small molecules for the treatment of infectious diseases... Read more
Avexa is a biotechnology company focusing on the development and commercialization of small molecules for the treatment of infectious diseases... Read more
News
May 06, 2017
BioPortfolio
Avexa: Avexa Ltd AVX Pharmaceuticals Healthcare Deals and Alliances Profile Updated 24042017 Prices from USD $250
Mar 01, 2017
BioPortfolio
Avexa: Avexa Ltd AVX Pharmaceuticals Healthcare Deals and Alliances Profile Updated 17022017 Prices from USD $250
Jan 13, 2017
BioPortfolio
Avexa: Avexa Ltd AVX Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250
Dec 15, 2016
BioPortfolio
Avexa: Avexa Limited Mergers Acquisitions MA Partnerships Alliances and Investment Report Prices from USD $350
Dec 06, 2016
BioPortfolio
Avexa: Avexa Ltd AVX Financial and Strategic SWOT Analysis Review Prices from USD $125
Nov 28, 2016
BioPortfolio
Avexa: Avexa Limited AVXDA Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250
Jul 23, 2016
Proactive Investors
Avexa: Avexa Ltd to update on capital raising
Apr 27, 2016
4-traders
Avexa: Avexa : Appendix 4C - Quarterly Cash Flow Report - March 2016
Mar 29, 2016
4-traders
Avexa: Avexa : Change of Director's Interest Notic
Mar 21, 2016
4-traders
Avexa: Avexa : SPP - Appendix 3B
